Biomarkers in community-acquired pneumonia: A state-of-the-art review

Authors

  • Renato Seligman Hospital de Clínicas de Porto Alegre (HCPA); Servico de Medicina Interna
  • Luis Francisco Ramos-Lima Universidade Federal do Rio Grande do Sul; Faculdade de Medicina; Hospital de Clínicas de Porto Alegre (HCPA)
  • Vivian do Amaral Oliveira Universidade Federal do Rio Grande do Sul; Faculdade de Medicina; Hospital de Clínicas de Porto Alegre (HCPA)
  • Carina Sanvicente Universidade Federal do Rio Grande do Sul; Faculdade de Medicina; Hospital de Clínicas de Porto Alegre (HCPA)
  • Elyara F Pacheco Universidade Federal do Rio Grande do Sul; Faculdade de Medicina; Hospital de Clínicas de Porto Alegre (HCPA)
  • Karoline Dalla Rosa Universidade Federal do Rio Grande do Sul; Faculdade de Medicina; Hospital de Clínicas de Porto Alegre (HCPA)

DOI:

https://doi.org/10.6061/clinics/2012(11)17

Keywords:

Pneumonia, Biological Markers, Community-Acquired Infections

Abstract

Community-acquired pneumonia (CAP) exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for searching for antibiotic therapy modifications and for CAP diagnosis, prognosis and follow-up treatment. This non-systematic state-of-the-art review presents the biological and clinical features of biomarkers in CAP patients, including procalcitonin, C-reactive protein, copeptin, pro-ANP (atrial natriuretic peptide), adrenomedullin, cortisol and D-dimers.

Downloads

Download data is not yet available.

Downloads

Published

2012-11-01

Issue

Vol. 67 No. 11 (2012)

Section

Reviews

How to Cite

Seligman, R., Ramos-Lima, L. F., Oliveira, V. do A., Sanvicente, C., Pacheco, E. F., & Dalla Rosa, K. (2012). Biomarkers in community-acquired pneumonia: A state-of-the-art review. Clinics, 67(11), 1321-1325. https://doi.org/10.6061/clinics/2012(11)17